Buy Retrophin Stock | RTRX Stock Price & Latest News | Public.com
RTRX

Retrophin

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Retrophin (RTRX) stock trends here

    About RTRX

    Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.79
    -1.58
    -2.37
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.46

    Actual EPS
    Q1 2021

    Stats

    Market Cap$1,57B
    Volume1
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$33.09
    1 Year Low$8.98
    Open$28.86
    High$29.97
    Low$27.39

    Buy any stock with any amount of money.

    Download the App
    Download the app